Mike Sullivan appointed president of Avion Pharmaceuticals

18 March 2014
40190792v2v1

Avion Pharmaceuticals, a US-based specialty pharmaceutical company, has announced the promotion of Mike Sullivan to the position of president.

Mr Sullivan joined Avion Pharmaceuticals in 2011 as Vice President of Sales and Marketing. With his expertise in building corporate “start-up” pharmaceutical organizations, he has been instrumental in the commercial development, infrastructure and launch of Avion over the past three years.

Through his experience in sales management, managed care, trade, sales operations, product management and training, Mr Sullivan has headed eight product launches in the span of Avion's history while also re-launching the Prenate Prenatal Vitamin Family, the makers of Prenate Mini – trusted to support women's prenatal health and nutrition.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical